Matches in Wikidata for { <http://www.wikidata.org/entity/Q93009316> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q93009316 description "artículu científicu espublizáu en payares de 2018" @default.
- Q93009316 description "scientific article published on 13 November 2018" @default.
- Q93009316 description "wetenschappelijk artikel" @default.
- Q93009316 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q93009316 name "Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors" @default.
- Q93009316 name "Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors" @default.
- Q93009316 type Item @default.
- Q93009316 label "Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors" @default.
- Q93009316 label "Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors" @default.
- Q93009316 prefLabel "Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors" @default.
- Q93009316 prefLabel "Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors" @default.
- Q93009316 P1433 Q93009316-4A094709-377F-4D23-A42E-5828B031C1DD @default.
- Q93009316 P1476 Q93009316-76E521F0-23E1-4ACA-BA58-C6D048CF6067 @default.
- Q93009316 P2093 Q93009316-3E66B680-B020-40FE-90A3-4E4C57E1D29F @default.
- Q93009316 P2093 Q93009316-42E04940-9F7C-456A-8C69-62F8F8252CAF @default.
- Q93009316 P2093 Q93009316-4B8097D2-27BD-4116-A6BB-F655AF90CF18 @default.
- Q93009316 P2093 Q93009316-4C1E5D0F-4FB8-4C9C-88E8-4D305B62E437 @default.
- Q93009316 P2093 Q93009316-8F5B5F02-972A-4213-8532-F02A53E64581 @default.
- Q93009316 P2093 Q93009316-9FF97144-EAAD-4AD3-ACCD-08069A6FF4B7 @default.
- Q93009316 P2093 Q93009316-BDCBCD8A-AD35-4207-8E76-B1C85F8BA734 @default.
- Q93009316 P2093 Q93009316-D350A064-0B03-4F2B-A252-63F9E98EE7C8 @default.
- Q93009316 P2093 Q93009316-D6337026-BFE4-4CE0-ACA2-70C4957D9466 @default.
- Q93009316 P2093 Q93009316-E597E51F-5A01-48BF-BF60-6816BAE91810 @default.
- Q93009316 P2093 Q93009316-F27CBE7D-E635-416A-B89F-8497928740CB @default.
- Q93009316 P304 Q93009316-29CC454A-1220-481E-8A72-37514155C165 @default.
- Q93009316 P31 Q93009316-624AB487-DE40-4ABC-8FAF-E2FCC652BC98 @default.
- Q93009316 P356 Q93009316-AEE3277E-A4FC-4A9A-A052-451014FFBFA6 @default.
- Q93009316 P433 Q93009316-9E450407-89EA-4789-A666-116ADAB09DEC @default.
- Q93009316 P478 Q93009316-4192D0B6-3C8A-4F06-8A96-A5DC696B902A @default.
- Q93009316 P577 Q93009316-2DA0E86D-EE0C-4A75-9EA5-56A5355EA8BE @default.
- Q93009316 P698 Q93009316-2C51A7E3-2923-4726-BC9F-5D7193080D35 @default.
- Q93009316 P921 Q93009316-2D1E32AD-601A-4516-BF56-ABC2A587011A @default.
- Q93009316 P356 000492344 @default.
- Q93009316 P698 30419558 @default.
- Q93009316 P1433 Q26842274 @default.
- Q93009316 P1476 "Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors" @default.
- Q93009316 P2093 "Ana M Vargas-Prado" @default.
- Q93009316 P2093 "Arancha Dueñas-Comino" @default.
- Q93009316 P2093 "David Aguiar-Bujanda" @default.
- Q93009316 P2093 "Jose E Lorenzo-Barreto" @default.
- Q93009316 P2093 "Laura Ros-Sanjuan" @default.
- Q93009316 P2093 "Maria Hernandez-Sosa" @default.
- Q93009316 P2093 "Maria J Blanco-Sanchez" @default.
- Q93009316 P2093 "Marta Mori-De Santiago" @default.
- Q93009316 P2093 "Salvador Saura-Grau" @default.
- Q93009316 P2093 "Saray Galvan-Ruiz" @default.
- Q93009316 P2093 "Uriel Bohn-Sarmiento" @default.
- Q93009316 P304 "755-761" @default.
- Q93009316 P31 Q13442814 @default.
- Q93009316 P356 "10.1159/000492344" @default.
- Q93009316 P433 "12" @default.
- Q93009316 P478 "41" @default.
- Q93009316 P577 "2018-11-13T00:00:00Z" @default.
- Q93009316 P698 "30419558" @default.
- Q93009316 P921 Q3658562 @default.